SFG
AIM

SNS Financial Group’s AIM ImmunoTech AIM Stock Holding History

SNS Financial Group’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$4.4K – 196
2023
Q4 		$4.4K Hold
100
– – ﹤0.01% 189
2023
Q3 		$4.55K Hold
100
– – ﹤0.01% 182
2023
Q2 		$6.7K Hold
100
– – ﹤0.01% 187
2023
Q1 		$4.3K Hold
100
– – ﹤0.01% 185
2022
Q4 		$3.12K Hold
100
– – ﹤0.01% 199
2022
Q3 		$6K Hold
100
– – ﹤0.01% 192
2022
Q2 		$8K Hold
100
– – ﹤0.01% 199
2022
Q1 		$11K Hold
100
– – ﹤0.01% 224
2021
Q4 		$9K Hold
100
– – ﹤0.01% 243
2021
Q3 		$20K Hold
100
– – ﹤0.01% 226
2021
Q2 		$22K Buy
+100
New +$21.4K ﹤0.01% 221

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

SNS Financial Group's AIM Position: Q1 2024 in Review

SNS Financial Group sold out of AIM ImmunoTech (AIM) in Q1 2024, closing a stake of 100 shares — an estimated $4.4K sold.

SNS Financial Group first reported a position in AIM in Q2 2021 and held it in 11 quarters. The position peaked at $22K in Q2 2021. 28 funds tracked by Wall St. Rank hold AIM as of Q1 2024.

  • SNS Financial Group reported no remaining AIM ImmunoTech position as of Q1 2024 after selling out during the quarter.
  • SNS Financial Group sold 100 AIM ImmunoTech shares in Q1 2024, an estimated $4.4K.
  • SNS Financial Group first reported a position in AIM ImmunoTech in Q2 2021 and held it in 11 quarters.
  • SNS Financial Group's AIM ImmunoTech position peaked at $22K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2024.

Based on SNS Financial Group's 13F filing for Q1 2024, filed 24 Apr 2024.